Molecular Function |
GO:0004602 |
Glutathione peroxidase activity |
0.0013 |
11 |
GO:0015278 |
Calcium-release channel activity |
0.0083 |
11 |
GO:0043560 |
Insulin receptor substrate binding |
0.0085 |
11 |
GO:0031490 |
Chromatin DNA binding |
0.0100 |
49 |
Biological process |
GO:0009235 |
Cobalamin metabolic process |
0.0014 |
13 |
GO:0001573 |
Ganglioside metabolic process |
0.0025 |
16 |
GO:0045682 |
Regulation of epidermis development |
0.0026 |
30 |
GO:0046033 |
AMP metabolic process |
0.0037 |
13 |
GO:0019082 |
Viral protein processing |
0.0044 |
10 |
GO:1901068 |
Guanosine-containing compound metabolic process |
0.0047 |
24 |
GO:0033194 |
Response to hydroperoxide |
0.0060 |
14 |
GO:0007220 |
Notch receptor processing |
0.0061 |
18 |
GO:0035357 |
Peroxisome proliferator activated receptor signaling pathway |
0.0066 |
12 |
GO:0008206 |
Bile acid metabolic process |
0.0077 |
20 |
GO:0032515 |
Negative regulation of phosphoprotein phosphatase activity |
0.0083 |
13 |
GO:0070987 |
Error-free translesion synthesis |
0.0091 |
14 |
GO:0045123 |
Cellular extravasation |
0.0097 |
29 |
Reactome |
R-HSA-1660661 |
Sphingolipid de novo biosynthesis |
0.0022 |
24 |
R-HSA-428157 |
Sphingolipid metabolism |
0.0043 |
48 |
R-HSA-977444 |
GABA B receptor activation |
0.0064 |
18 |
R-HSA-977443 |
GABA receptor activation |
0.0066 |
19 |
R-HSA-997272 |
Inhibition of voltage gated Ca2+channels via Gbeta/gamma subunits |
0.0074 |
11 |
R-HSA-400042 |
Inhibition of insulin secretion by adrenaline noradrenaline |
0.0075 |
16 |
R-HSA-1296065 |
Inwardly rectifying K channels |
0.0089 |
12 |